For cervical and uterine cancer. Sold as Ic-Green, Spy Agent Green, Zyogreen. Every FDA application for this active ingredient: 3 branded and 2 generic.
As of Nov 16, 2026, FDA lists 5 applications for Indocyanine Green (sold as Ic-Green, Spy Agent Green, Zyogreen), first approved Feb 9, 1959, with 2 new uses approved and 0 published complete response letters.
| Comparison of Superficial-Only Versus Combined Indocyanine Green Injection Techniques for Sentinel Lymph Node Mapping in Patients With Endometrial CancerEndometrial Cancer · Barretos Cancer Hospital | Not applicable | Not yet recruiting | Nov 4, 2026 |
| FLuorescent Angiography in REduction of Anastomotic Leak in Rectal Cancer SurgeryRectal Cancer Patients, Rectal Cancer Surgery · Basavatarakam Indo American Cancer Hospital & Research Institute | Not applicable | Not yet recruiting | Oct 27, 2026 |
| Use of Reconstructive Microsurgery for the Treatment of LymphedemaLymphedema · Istituto Ortopedico Rizzoli | — | Recruiting | Oct 22, 2026 |
| LECS Combined With LSNNS for Early Gastric Cancer (LENS Trial)Early Gastric Cancer · Peking University People's Hospital | — | Recruiting | Oct 5, 2026 |
| Cervical Lymphatic Microsurgery in Alzheimer's DiseaseAlzheimer Disease · Daniel Maliszewski | Not applicable | Recruiting | Oct 5, 2026 |
| Restoring Cervical Lymphatic Drainage in Alzheimer's DiseaseAlzheimer, Alzheimer Dementia (AD) · University of Siena | Not applicable | Recruiting | Oct 2, 2026 |
| Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric CancerEarly Gastric Cancer, Gastric Adenocarcinoma · Beijing Friendship Hospital | Not applicable | Recruiting | Sep 22, 2026 |
| Indocyanine Green With Near Infrared Imaging for Intraoperative Visualization of Head and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma · Washington University School of Medicine | Phase 2 | Recruiting | Sep 17, 2026 |
| Feb 9, 1959 | Ic-GreenNDA 11525 · New molecular entity | Renew Pharms | 12 | Marketed |
| Nov 21, 2007 | Indocyanine GreenANDA 40811 | Renew Pharms | 2 | Marketed |
| Nov 21, 2018 | Spy Agent GreenNDA 211580 · New formulation or manufacturer | Novadaq Tech | 3 | Marketed |
| Jul 10, 2026 | ZyogreenNDA 218579 · New dosage form | Provepharm Sas | 0 | Marketed |
| Aug 3, 2026 | Indocyanine GreenANDA 219139 | Zydus Lifesciences | 0 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA